BMAL1 and diabetes mellitus: Mechanistically, β-cell-specific Bmal1 overexpression enhanced the effects of nobiletin on pancreatic circadian rhythms and insulin secretion, highlighting the key role of Bmal1 in interventions in diabetes [77].